Webinar: Transitioning from Hemochron Response to Hemochron Signature Elite - Case Study
Accriva Diagnostics
0:00 / 0:00
Webinar: Transitioning from Hemochron Response to Hemochron Signature Elite - Case Study
3 109 просмотров · 9 лет назад
Accriva Diagnostics
198 подписчиков
3 109 просмотров · 9 лет назад
Recording of a live webinar held on Tuesday, February 28, 2017, entitled "Transitioning from Hemochron Response to the Signature Elite - A Case Study". Guest presenter Mary Jo Grodsky BS, MLS (ASCP), Point of Care Coordinator for Orlando Regional Medical Center, details best practices of converting from a tube-based to a cuvette-based ACT point-of-care test system. She shares the various aspects and key learnings from Orlando Regional’s own conversion of over 30 Hemochron Response tube-based systems to the Signature Elite cuvette-based system.
At the conclusion of this webinar participants will understand:
1) The key feature differences between advantages of a cuvette-based microcoagulation system vs. a tube-based system
2) How to set expectations for therapeutic ranges and test performance
3) Best practices for conversion across multiple departments and,
4) How a cuvette-based system, such as the Signature Elite, benefits both the patient and the clinician.